EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HYPOPHARYNX

被引：8

作者：

FRANK, JL

GARB, JL

BANSON, BB

PETERMAN, J

NEIFELD, JP

KAY, S

KORNSTEIN, MJ

SISMANIS, A

WARE, JL

机构：

[1] Division of Surgical Oncology, Department of Surgery Baystate Medical Center, Tufts University School of Medicine, Springfield, MA

[2] Department of Pathology, Baystate Medical Center, Tufts University School of Medicine, Springfield, MA

[3] Division of Surgical Oncology, Department of Surgery, Medical College of Virginia, Richmond, VA

[4] Department of Pathology, Medical College of Virginia, Richmond, VA

[5] Department of Otolaryngology, Medical College of Virginia, Richmond, VA

来源：

SURGICAL ONCOLOGY-OXFORD | 1993年 / 2卷 / 03期

关键词：

EPIDERMAL GROWTH FACTOR RECEPTOR; HEAD AND NECK CANCER; MULTIVARIATE ANALYSIS; SURVIVAL;

D O I：

10.1016/0960-7404(93)90003-H

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Expression of the epidermal growth factor receptor (EGFR) has been demonstrated in normal and malignant squamous epithelia. Its presence has been suggested to be important in the pathophysiology and prognosis of epithelial cancers. Archival tumour specimens from 57 patients with squamous cell carcinoma of the hypopharynx were studied using OM-11-951, a new murine anti-EGFR monoclonal antibody which recognizes the receptor on deparaffinized tissue. By visual inspection, 28 (49%) tumours were EGFR negative; 29 (51%) tumours were EGFR positive. While patients whose tumours were EGFR positive were younger, there was no significant correlation with other clinical or pathological variables (including grade and stage). Patients whose tumours were EGFR negative had a median survival of 21 (95% CI 4.3-37.7) months compared with a median survival of 17 (95% CI 11.4-22) months for patients whose tumours were EGFR positive. The difference was not statistically significant. A multiple regression analysis did not demonstrate EGFR status to be important in predicting survival. These data cast doubt on the prognostic significance of EGFR expression in this neoplasm.

引用

页码：161 / 167

页数：7

共 22 条

[1]

Ozanne, Richards, Hendler, Et al., Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas, J Pathol, 149, pp. 9-14, (1986)

[2]

Nakagawa, Yoshida, Hirao, Et al., Biological effects of biosynthetic human EGF on the growth of mammalian cells in vitro, Differentiation, 29, pp. 284-288, (1985)

[3]

Weber, Pathak, Frankenthaler, Et al., Effect of epidermal growth factor (EGF) on a newly established head and neck squamous carcinoma cell line, Oto-laryngol Head Neck Surg, 99, pp. 567-573, (1988)

[4]

Rabiasz, Langdon, Bartlett, Et al., Growth control by EGF and TGF-alpha in human lung squamous carcinoma cells, Br J Cancer, 66, pp. 254-259, (1992)

[5]

Ishitoya, Toriyama, Oguchi, Et al., Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck, Br J Cancer, 59, pp. 559-562, (1989)

[6]

Weichselbaum, Dunphy, Beckett, Et al., Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines, Head and Neck, 11, pp. 437-442, (1989)

[7]

Yano, Shiozaki, Kobayashi, Et al., Immunohisto-logic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma, Cancer, 67, pp. 91-98, (1991)

[8]

Mukaida, Toi, Hirai, Yamashita, Et al., Clinical significance of epidermal growth factor and its receptor in esophageal cancer, Cancer, 68, pp. 142-148, (1991)

[9]

Sainsbury, Farndon, Sherbet, Et al., Epidermal growth factor receptors and oestrogen receptors in human breast cancer, Lancet, 1, pp. 364-366, (1985)

[10]

Neal, Sharples, Smith, Et al., The epidermal growth factor receptor and the prognosis of bladder cancer, Cancer, 65, pp. 1619-1625, (1990)

← 1 2 3 →